There is evidence that GLRX expression increases in atherosclerotic coronary arteries (Okuda et al., 2001) and patients with type 2 diabetes (Du et al., 2014), suggesting that the upregulation of GLRX expression might contribute to inflammation and oxidative stress. This evidence concerns the gene GLRX and type 2 diabetes mellitus.